Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients

Background. Despite the well known association between interleukin-6 (IL-6) and cardiovascular mortality, no study has so far verified whether IL-6 adds prognostic information to that provided by C-reactive protein (CRP). Methods. A cohort of 218 haemodialysis patients from four different dialytic c...

Full description

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2004-05, Vol.19 (5), p.1154-1160
Main Authors: Panichi, Vincenzo, Maggiore, Umberto, Taccola, Daniele, Migliori, Massimiliano, Rizza, Giovanni Manca, Consani, Cristina, Bertini, Alessio, Sposini, Stefano, Perez-Garcia, Rafael, Rindi, Paolo, Palla, Roberto, Tetta, Ciro
Format: Article
Language:English
Subjects:
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Biomarkers - blood
C-reactive protein
C-Reactive Protein - analysis
Cardiovascular Diseases - mortality
cardiovascular mortality
Cohort Studies
Databases, Factual
Emergency and intensive care: renal failure. Dialysis management
Female
Glomerulonephritis
haemodialysis
Humans
Intensive care medicine
interleukin-6
Interleukin-6 - blood
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
outcome
Predictive Value of Tests
Renal Dialysis - mortality
Reproducibility of Results
Retrospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Despite the well known association between interleukin-6 (IL-6) and cardiovascular mortality, no study has so far verified whether IL-6 adds prognostic information to that provided by C-reactive protein (CRP). Methods. A cohort of 218 haemodialysis patients from four different dialytic centres was followed-up retrospectively. Plasma IL-6 and CRP concentrations were determined. Full information on co-morbidities was available in 162 patients. Results. With respect to the lowest quartile (< 3.6 pg/ml for IL-6, and < 2.2 mg/l for CRP), the crude relative risk (RR) of death from all causes of the upper quartile (> 13.9 pg/ml for IL-6, and > 12.8 mg/l for CRP) was 5.20 (95% confidence interval 2.06–13.011) for IL-6 and 3.16 (1.41–7.12) for CRP. When both variables were included, the estimates were 4.10 (1.30–12.96) for IL-6 and 1.29 (0.47–3.57) for CRP. As to continuous variables, the relationship between both variables and mortality tended to level off for the highest values, but became fairly linear after log transformation of the variables. For one unit SD of the log (variable), the RR was 2.09 (1.52–2.88) for IL-6 and 1.66 (1.23–2.24) for CRP. When they were included in the same model, the estimates were 1.90 (1.18–2.82) for IL-6 and 1.16 (0.81–1.66) for CRP. Conclusions. IL-6 has a stronger predictive value than CRP for cardiovascular mortality and provides independent prognostic information, while conveying most of that provided by CRP.
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfh052